Welcome to the the future of Pharmaceutical Development
As of 2019, the cost of developing a new medicine is approximately $2.6 billion. This cost is unsustainable.
Development costs are set to increase and the ability of Government's to pay for advanced therapies is reducing year on year.
Rapid advances in genomics and the medical sciences, opens the possibility of step changes in treatment based on individualised medicines. The benefits though will only be gained if research and the ability to choose between drug candidates becomes faster, cheaper and far more efficient.
Fast Regulatory review and licensing is crucial, combined with a rapid and targeted drug launch.
The classical business model of pharmaceutical development has to change.
PharmaMedic gives you the future - A Virtual Pharma Solution.
The Partnership brings together World experts in Product Development, Regulatory Strategy, Product Launch, Training and Medical Writing. The capabilities of large pharma are now available to SME's / Biotech Phase II / III and Academic centres.
By combining the "Best of the Best", we are the best at what we do.
Costs are reduced, expertise is a given, and a tailored development approach is yours every step of the way.